Afeyan Noubar's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed May 26, 2023
- Accession no.
- 0000899243-23-013992
- Filed
- May 26, 2023, 8:00 PM ET
- Trade date
- May 24-26, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.53M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Ventures Fund V, L.P.CIK 0001627639 | 10% Owner |
| Flagship Ventures Fund V General Partner LLCCIK 0001724575 | 10% Owner |
| Flagship V VentureLabs Rx Fund, L.P.CIK 0001724939 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Common Stock | SSaleDisposed | −308,290 | $6.57 | −$2,023,985.51 | 11,276,909 | Indirect | |
| May 24, 2023 | Common Stock | SSaleDisposed | −39,580 | $6.57 | −$259,850.62 | 1,447,791 | Indirect | |
| May 25, 2023 | Common Stock | SSaleDisposed | −102,245 | $6.35 | −$649,480.69 | 11,174,664 | Indirect | |
| May 25, 2023 | Common Stock | SSaleDisposed | −13,127 | $6.35 | −$83,385.33 | 1,434,664 | Indirect | |
| May 26, 2023 | Common Stock | SSaleDisposed | −72,670 | $6.23 | −$452,479.76 | 11,101,994 | Indirect | |
| May 26, 2023 | Common Stock | SSaleDisposed | −9,330 | $6.23 | −$58,093.25 | 1,425,334 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.